Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment
暫譯: 高血壓與心臟衰竭：流行病學、機制與治療
Dorobantu, Maria, Mancia, Giuseppe, Grassi, Guido
- 出版商: Springer
- 出版日期: 2019-04-10
- 售價: $5,910
- 貴賓價: 9.5 折 $5,615
- 語言: 英文
- 頁數: 416
- 裝訂: Hardcover - also called cloth, retail trade, or trade
- ISBN: 3319933191
- ISBN-13: 9783319933191
海外代購書籍(需單獨結帳)
相關主題
商品描述
In this context the international scientific community is continuously struggling to develop better strategies in screening, diagnosing and treating hypertension and its deleterious effects. Thus, this field is continuously changing, with new important information being added constantly.
This volume will offer both insights into the intimate mechanisms of transition from hypertension to heart failure and clinical practice advice on the prevention and treatment of heart failure in hypertensive population. The mechanisms which explain the progression from hypertension to heart failure will be also covered exhaustively by offering two chapters referring to the diagnosis of heart failure in hypertensive population and one regarding echocardiography which is the most frequently used imaging method in clinical practice. The reader will be also provided with information on cardiovascular magnetic resonance which has the unique advantage of differentiating hypertensive heart failure from other pathologies associated with increased myocardial thickness.
This book is a useful tool for clinicians but also to the research community interested in heart failure and consequences of hypertension on heart who want to be up-to-date with the new developments in the field.
商品描述(中文翻譯)
本書解釋了高血壓如何影響發達國家20-50%的成人人口。心臟衰竭是高血壓對心臟影響的結果，並且它代表了一個日益嚴重的公共健康問題。
在這個背景下，國際科學界不斷努力開發更好的篩檢、診斷和治療高血壓及其有害影響的策略。因此，這個領域不斷變化，新的重要資訊不斷被添加。
本卷將提供有關高血壓轉變為心臟衰竭的內部機制的見解，以及針對高血壓人群心臟衰竭的預防和治療的臨床實踐建議。解釋高血壓進展至心臟衰竭的機制也將被全面涵蓋，提供兩章有關高血壓人群心臟衰竭診斷的內容，以及一章關於心臟超音波，這是臨床實踐中最常用的影像學方法。讀者還將獲得有關心血管磁共振的資訊，這種技術具有獨特的優勢，可以區分高血壓性心臟衰竭與其他與心肌厚度增加相關的病理。
本書對於臨床醫生以及對心臟衰竭和高血壓對心臟影響感興趣的研究社群來說，都是一個有用的工具，幫助他們跟上該領域的新發展。
作者簡介
Since 2016 she has been the chairperson of the Coronary Pathophysiology and Microcirculation Working Group of Europeam Society of Cardiology.
Giuseppe Mancia is Professor Emeritus of the University of Milano and Head of the Hypertension Centre of the Instituto Clinico Universitario, Verano Brianza. He is President of the Italian Foundation on "Ricerca e Innovazione su Ipertensione e Protezione Cardiovascolare", of the Foundation of the European Society of Hypertension (ESH) in Zurich and Chairman of the Educational Board of ESH.
He is since many years in the list of the "highly cited" scientists (Thompson Reuters) and has in 2013 been regarded as one of the 400 most influential biomedical investigators in the world (EJCI 2013).
Guido Grassi is Professor of Internal Medicine at the Clinica Medica of the University of Milano, director of the PhD course in "Hypertension and Cardiovascular Risk", and director of the Center of Clinical Physiology and Hypertension of the same university.
He is member of the Scientific Council on Hypertension of the ESC, ESH and ISH. He is also member of the ESH/ESC Task Force Guidelines on the Management of Hypertension.
He is Executive Editor of "Journal of Hypertension", official Journal of the ISH and the ESH.
Victor Voicu is currently fellow the and vice president of Romanian Academy and President of Medical Science Section of Romanian Academy. He is Professor of Department of Pharmacology, Toxicology and Clinical Psychopharmacology, Faculty of Medicine, University of Medicine and Pharmacy "Carol Davila" Bucharest. He is President of the Romanian Society of Therapeutics, Pharmacology and Clinical Toxicology, and coordinator of Drug Sciences Panel of the Executive Unit for Financing of Higher Education, Research, Development and Innovation (EUFHERDI). Prof. Voicu is correspondent member from abroad of French National Academy of Medicine.
作者簡介(中文翻譯)
瑪莉亞·多羅班圖是羅馬尼亞布加勒斯特卡羅爾·達維拉醫藥大學的心臟病學教授，並擔任布加勒斯特臨床急救醫院心臟病學系主任。她對心臟衰竭和動脈高血壓的評估與治療特別感興趣，並曾擔任多項重要臨床試驗的主要研究者。她是羅馬尼亞高血壓學會的會長，也是SEPHAR研究（羅馬尼亞成人高血壓和心血管風險流行率評估研究）的國家協調員。
自2016年以來， 她一直是歐洲心臟病學會冠狀動脈病理生理學與微循環工作組的主席。
朱塞佩·曼恰是米蘭大學的名譽教授，並擔任維拉諾·布里安扎臨床大學醫院高血壓中心的主任。他是意大利「高血壓與心血管保護研究與創新基金會」的會長，也是位於蘇黎世的歐洲高血壓學會（ESH）基金會的會長，並擔任ESH教育委員會的主席。
他多年來一直在「高被引」科學家名單上（湯姆森路透），並於2013年被認為是全球400位最具影響力的生物醫學研究者之一（EJCI 2013）。
圭多·格拉西是米蘭大學內科醫學教授，並擔任「高血壓與心血管風險」博士課程的主任，以及同大學臨床生理學與高血壓中心的主任。
他是歐洲心臟病學會（ESC）、歐洲高血壓學會（ESH）和國際高血壓學會（ISH）高血壓科學委員會的成員。他也是ESH/ESC高血壓管理指導方針的成員。
他是《高血壓期刊》的執行編輯，該期刊是ISH和ESH的官方期刊。
維克多·沃伊庫目前是羅馬尼亞科學院的研究員和副院長，並擔任羅馬尼亞科學院醫學科學部的會長。他是布加勒斯特卡羅爾·達維拉醫藥大學藥理學、毒理學和臨床精神藥理學系的教授。他是羅馬尼亞治療學、藥理學和臨床毒理學學會的會長，並擔任高等教育、研究、發展和創新資助執行單位（EUFHERDI）藥物科學小組的協調員。沃伊庫教授是法國國家醫學院的外籍通訊成員。
